Amivantamab price list

Introduction: Amivantamab can be used alone to treat non-small cell lung cancer (non-small cell lung cancer) in patients who have an abnormal epidermal growth factor receptor (EGFR) gene (exon 20 insertion mutation) and have received other cancer drugs (such as platinum), but have not responded well. The disease has spread (metastatic) or cannot be removed by surgery or radiotherapy (locally advanced).

Amivantamab can also be used in combination with carboplatin and pemetrexed as a first-line treatment for metastatic or locally advanced non-small cell lung cancer in patients with EGFR gene abnormalities (exon 20 insertion mutations).

Amivantamab (Amivantamab) original drug and generic drug prices

Currently there is only the original drug and no generic version, so the price of generic drugs is temporarily unknown. It is currently known that the price of the generic drug Evantumumab produced by Janssen Pharmaceuticals in the United States is about 10,300$-11,000$ per box, and the specification of one box is 350mg/7ml.

may vary depending on regions, suppliers, purchasing channels and other factors. If you need the latest price information, it is recommended to consult your local medical institution or drug supplier. At the same time, since evantumumab is a prescription drug, you should consult a professional doctor before use and follow the medical advice.

Usage and dosage of evantumumab

The recommended dose of evantumumab for patients weighing <80kg is 1050mg, and for patients weighing ≥80kg, the recommended dose is 1400mg. Premedication is recommended, with administration via peripheral lines during weeks 1 and 2. The initial dose is given as two infusions, one on Days 1 and 2 of Week 1. After completing the initial two infusions, evantumumab infusions were continued weekly for 4 weeks.

Starting from week 5, the dosage will be changed to once every 2 weeks, and this dosage frequency will be maintained until disease progression or unacceptable toxicity occurs.

Evantumumab is a prescription drug. Patients should strictly follow the doctor's instructions, take the drug on time and in the right amount, and pay close attention to changes in their condition and possible adverse reactions.

Adverse reactions of evantumumab

The most common adverse reactions of evantumumab include rash, nail toxicity, stomatitis, infusion-related reactions, fatigue, edema, constipation, decreased appetite, nausea, diarrhea, vomiting, etc. No cardiovascular toxic events related to evantumumab have been found yet.

If an adverse reaction occurs, you can inform the doctor in time, and the doctor will decide whether to carry out targeted treatment based on the severity.